These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25330161)

  • 1. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.
    Danel C; Kabran M; Inwoley A; Badje A; Herrmann JL; Moh R; Lecarrou J; Gabillard D; Ntakpe JB; Deschamps N; Ouattara E; Perronne C; Eholie S; Anglaret X
    PLoS One; 2014; 9(10):e107245. PubMed ID: 25330161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis.
    Santin M; Muñoz L; Rigau D
    PLoS One; 2012; 7(3):e32482. PubMed ID: 22403663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
    Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
    Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response.
    Esmail H; Thienemann F; Oni T; Goliath R; Wilkinson KA; Wilkinson RJ
    BMC Infect Dis; 2016 Oct; 16(1):545. PubMed ID: 27717329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.
    Johnson JL; Geldenhuys H; Thiel BA; Toefy A; Suliman S; Pienaar B; Chheng P; Scriba T; Boom WH; Hanekom W; Hatherill M
    Chest; 2014 Mar; 145(3):612-7. PubMed ID: 24135768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
    Badje A; Moh R; Gabillard D; Guéhi C; Kabran M; Ntakpé JB; Carrou JL; Kouame GM; Ouattara E; Messou E; Anzian A; Minga A; Gnokoro J; Gouesse P; Emieme A; Toni TD; Rabe C; Sidibé B; Nzunetu G; Dohoun L; Yao A; Kamagate S; Amon S; Kouame AB; Koua A; Kouamé E; Daligou M; Hawerlander D; Ackoundzé S; Koule S; Séri J; Ani A; Dembélé F; Koné F; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatunde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Karcher S; Rouzioux C; Kouame A; Assi R; Bakayoko A; Domoua SK; Deschamps N; Aka K; N'Dri-Yoman T; Salamon R; Journot V; Ahibo H; Ouassa T; Menan H; Inwoley A; Danel C; Eholié SP; Anglaret X;
    Lancet Glob Health; 2017 Nov; 5(11):e1080-e1089. PubMed ID: 29025631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals.
    Aichelburg MC; Rieger A; Breitenecker F; Pfistershammer K; Tittes J; Eltz S; Aichelburg AC; Stingl G; Makristathis A; Kohrgruber N
    Clin Infect Dis; 2009 Apr; 48(7):954-62. PubMed ID: 19245343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study.
    Shah M; Kasambira TS; Adrian PV; Madhi SA; Martinson NA; Dorman SE
    PLoS One; 2011; 6(10):e26787. PubMed ID: 22066009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis.
    Lagrange PH; Thangaraj SK; Dayal R; Deshpande A; Ganguly NK; Girardi E; Joshi B; Katoch K; Katoch VM; Kumar M; Lakshmi V; Leportier M; Longuet C; Malladi SV; Mukerjee D; Nair D; Raja A; Raman B; Rodrigues C; Sharma P; Singh A; Singh S; Sodha A; Kabeer BS; Vernet G; Goletti D
    PLoS One; 2013; 8(9):e73579. PubMed ID: 24039990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
    Khawcharoenporn T; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Apisarnthanarak A
    Jpn J Infect Dis; 2017 Sep; 70(5):502-506. PubMed ID: 28367883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.
    Pullar ND; Steinum H; Tonby K; Heggelund L; Leiva RA; Ofstad R; Bruun JN; Dyrhol-Riise AM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):180-7. PubMed ID: 24429310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.
    Ghehi C; Gabillard D; Moh R; Badje A; Kouamé GM; Oouttara E; Ahibo H; N'Takpé JB; Lecarrou J; Eholié SP; Anglaret X; Danel C
    PLoS One; 2017; 12(6):e0177440. PubMed ID: 28582393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
    Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
    BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.
    Andrews JR; Nemes E; Tameris M; Landry BS; Mahomed H; McClain JB; Fletcher HA; Hanekom WA; Wood R; McShane H; Scriba TJ; Hatherill M
    Lancet Respir Med; 2017 Apr; 5(4):282-290. PubMed ID: 28215501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.